Abbott NJ, Ronnback L, Hansson E (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7:41–53. https://doi.org/10.1038/nrn1824

Article  CAS  PubMed  Google Scholar 

Abdelfattah N, Kumar P, Wang C, Leu JS, Flynn WF, Gao R et al (2022) Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target. Nat Commun 13:767. https://doi.org/10.1038/s41467-022-28372-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

Adhikari E, Liu Q, Johnson J, Stewart P, Marusyk V, Fang B et al (2023) Brain metastasis-associated fibroblasts secrete fucosylated PVR/CD155 that induces breast cancer invasion. Cell Rep 42:113463. https://doi.org/10.1016/j.celrep.2023.113463

Article  CAS  PubMed  Google Scholar 

Aguirre-Ghiso JA (2007) Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer 7:834–846. https://doi.org/10.1038/nrc2256

Article  CAS  PubMed  PubMed Central  Google Scholar 

Akanda MR, Ahn EJ, Kim YJ, Salam SMA, Noh MG, Kim SS et al (2023) Different expression and clinical implications of cancer-associated fibroblast (CAF) markers in brain metastases. J Cancer 14:464–479. https://doi.org/10.7150/jca.80115

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alkins R, Burgess A, Kerbel R, Wels WS, Hynynen K (2016) Early treatment of HER2-amplified brain tumors with targeted NK-92 cells and focused ultrasound improves survival. Neuro Oncol 18:974–981. https://doi.org/10.1093/neuonc/nov318

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alkins R, Burgess A, Ganguly M, Francia G, Kerbel R, Wels WS et al (2013) Focused ultrasound delivers targeted immune cells to metastatic brain tumors. Cancer Res 73:1892–1899. https://doi.org/10.1158/0008-5472.Can-12-2609

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alvarez-Breckenridge C, Markson SC, Stocking JH, Nayyar N, Lastrapes M, Strickland MR et al (2022) Microenvironmental landscape of human melanoma brain metastases in response to immune checkpoint inhibition. Cancer Immunol Res 10:996–1012. https://doi.org/10.1158/2326-6066.CIR-21-0870

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alvarez-Prado AF, Maas RR, Soukup K, Klemm F, Kornete M, Krebs FS et al (2023) Immunogenomic analysis of human brain metastases reveals diverse immune landscapes across genetically distinct tumors. Cell Rep Med 4:100900. https://doi.org/10.1016/j.xcrm.2022.100900

Article  CAS  PubMed  PubMed Central  Google Scholar 

Angehagen M, Ben-Menachem E, Ronnback L, Hansson E (2003) Novel mechanisms of action of three antiepileptic drugs, vigabatrin, tiagabine, and topiramate. Neurochem Res 28:333–340. https://doi.org/10.1023/a:1022393604014

Article  CAS  PubMed  Google Scholar 

Arvanitis CD, Ferraro GB, Jain RK (2020) The blood-brain barrier and blood-tumour barrier in brain tumours and metastases. Nat Rev Cancer 20:26–41. https://doi.org/10.1038/s41568-019-0205-x

Article  CAS  PubMed  Google Scholar 

Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE (2004) Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 22:2865–2872. https://doi.org/10.1200/JCO.2004.12.149

Article  PubMed  Google Scholar 

Berghoff AS, Ricken G, Widhalm G, Rajky O, Dieckmann K, Birner P et al (2015) Tumour-infiltrating lymphocytes and expression of programmed death ligand 1 (PD-L1) in melanoma brain metastases. Histopathology 66:289–299. https://doi.org/10.1111/his.12537

Article  PubMed  Google Scholar 

Berghoff AS, Fuchs E, Ricken G, Mlecnik B, Bindea G, Spanberger T et al (2016) Density of tumor-infiltrating lymphocytes correlates with extent of brain edema and overall survival time in patients with brain metastases. Oncoimmunology 5:e1057388. https://doi.org/10.1080/2162402x.2015.1057388

Article  PubMed  Google Scholar 

Berrout J, Kyriakopoulou E, Moparthi L, Hogea AS, Berrout L, Ivan C et al (2017) TRPA1-FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3p. Nat Commun 8:947. https://doi.org/10.1038/s41467-017-00983-w

Article  CAS  PubMed  PubMed Central  Google Scholar 

Biermann J, Melms JC, Amin AD, Wang Y, Caprio LA, Karz A et al (2022) Dissecting the treatment-naive ecosystem of human melanoma brain metastasis. Cell 185:2591–608.e30. https://doi.org/10.1016/j.cell.2022.06.007

Article  CAS  PubMed  PubMed Central  Google Scholar 

Biswas AK, Han S, Tai Y, Ma W, Coker C, Quinn SA et al (2022) Targeting S100A9-ALDH1A1-Retinoic acid signaling to suppress brain relapse in EGFR-mutant lung cancer. Cancer Discov 12:1002–1021. https://doi.org/10.1158/2159-8290.CD-21-0910

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bos PD, Zhang XH, Nadal C, Shu W, Gomis RR, Nguyen DX et al (2009) Genes that mediate breast cancer metastasis to the brain. Nature 459:1005–1009. https://doi.org/10.1038/nature08021

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bowman RL, Klemm F, Akkari L, Pyonteck SM, Sevenich L, Quail DF et al (2016) Macrophage ontogeny underlies differences in tumor-specific education in brain malignancies. Cell Rep 17:2445–2459. https://doi.org/10.1016/j.celrep.2016.10.052

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bresnick AR, Weber DJ, Zimmer DB (2015) S100 proteins in cancer. Nat Rev Cancer 15:96–109. https://doi.org/10.1038/nrc3893

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brummel K, Eerkens AL, de Bruyn M, Nijman HW (2023) Tumour-infiltrating lymphocytes: from prognosis to treatment selection. Br J Cancer 128:451–458. https://doi.org/10.1038/s41416-022-02119-4

Article  CAS  PubMed  Google Scholar 

Bunse L, Bunse T, Kilian M, Quintana FJ, Platten M (2025) The immunology of brain tumors. Sci Immunol 10:eads0449. https://doi.org/10.1126/sciimmunol.ads0449

Article  CAS  PubMed  Google Scholar 

Cabrita R, Lauss M, Sanna A, Donia M, Skaarup Larsen M, Mitra S et al (2020) Tertiary lymphoid structures improve immunotherapy and survival in melanoma. Nature 577:561–565. https://doi.org/10.1038/s41586-019-1914-8

Article  CAS  PubMed  Google Scholar 

Cacho-Diaz B, Garcia-Botello DR, Wegman-Ostrosky T, Reyes-Soto G, Ortiz-Sanchez E, Herrera-Montalvo LA (2020) Tumor microenvironment differences between primary tumor and brain metastases. J Transl Med 18:1. https://doi.org/10.1186/s12967-019-02189-8

Article  PubMed  PubMed Central  Google Scholar 

Cagney DN, Martin AM, Catalano PJ, Redig AJ, Lin NU, Lee EQ et al (2017) Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study. Neuro Oncol 19:1511–1521. https://doi.org/10.1093/neuonc/nox077

Article  PubMed  PubMed Central  Google Scholar 

Carril-Ajuria L, Desnoyer A, Meylan M, Dalban C, Naigeon M, Cassard L et al (2022) Baseline circulating unswitched memory B cells and B-cell related soluble factors are associated with overall survival in patients with clear cell renal cell carcinoma treated with nivolumab within the NIVOREN GETUG-AFU 26 study. J Immunother Cancer. https://doi.org/10.1136/jitc-2022-004885

Article  PubMed  PubMed Central